POSTER TALK

[ddwalker87]

You too, Tina.

Hope you end up WAY GREEN!!!

[Tina]

morning dd have a good day

[ddwalker87]

INXR NEWS - Expect $4-5MM In Revenues a Year

iFinix Corporation Examines Market Share
Friday August 18, 9:00 am ET


JAMAICA, NY--(MARKET WIRE)--Aug 18, 2006 -- The Board of Directors of iFinix Corporation (Other OTC:INXR.PK - News) is pleased to release the results of a preliminary study of our prospective market size, potential market share and subsequent revenue potential.
ADVERTISEMENT


Corporate Chief Executive Officer, Mr. Douglas Spadaro, stated that: "Retail clients are increasingly looking for value from a broader set of financial tools. Through the compelling value proposition of our e-phoenix modality, they are able to respond to the ever changing market environment on a real time basis. By utilizing our suite of investing, trading, banking and analytical products, they remain ideally positioned to capitalize on short-term market opportunities and long-term secular growth trends."

Mr. Spadaro went on to say: "In our opinion, there are 100 plus competitors in our marketplace today. This establishes our concept as a growing trend, rather than an anomaly. You cannot have this many people spending a finite amount of dollars trying to go after a static customer base due to the fact that one needs enormous capitalization to play engage in this business. The resulting attrition of the less innovative products will open up a growing client base for the companies with a leading edge product offering. We believe that most of the copycat companies are going to go by the wayside and there will only be about four or five that will really be standing tall by the end of the decade."

Mr. Spadaro further stated: "What used to be a conventional battlefield has now really become guerrilla warfare with regard to the way the exchanges work and the ways the markets move. Trading system innovation and information access is the key."

Charles Schwab & Co. tops the list of online brokerage firms by reporting nearly 117,800 trades per day or 23 percent of the market. E*TRADE was number two with 76,333 trades per day or approximately 14.9 percent of the market. Management calculates that these trading figures equate to net income announcements of 251 million dollars and 156 million dollars, in the first and second quarter of 2006, respectively. These figures being proportional, one would expect that if the iFinix product suite were to attain a one tenth of one percent market share within its client base, the expected revenue generated by the iFinix product would be between four and five million dollars per year. No assurances can be given that iFinix would achieve this market shares or revenues.

About iFinix:

iFinix is a diversified information technology services and solutions company. Our people combine expertise in systems integration, outsourcing, infrastructure, server technology and consulting with precision thinking and relentless execution to help clients. iFinix is a leading global provider of financial and business information to professionals and active individual investors. Building on a 20-year legacy of delivering time-sensitive financial information, Phoenix provides streaming, real-time market data, news and analytics. The company's suite of products includes Phoenix Pro, the Phoenix Market Scanner, Phoenix Analyst and eifinix

[ddwalker87]

JMCP Merger Closing Soon -- With Eagle Insallation, Almost $2MM in Revenues Last Year

August 18, 2006 08:30:05 (ET)

CHICAGO, Aug 18, 2006 (BUSINESS WIRE) -- James Monroe Capital Corporation (Pink Sheets:JMCP) is closing-in on the acquisition of a manufacturing company, Eagle Installation, Incorporated.

The target acquisition, Eagle Installation, had 65 employees in multiple states, and revenues approaching $2 million last year. The company owns piles of industrial tools and manufacturing equipment, which could be used by Diversified Ethanol for manufacturing plants. Eagle Installation's owner, John Newby, has been offered a directorship and a position in charge of all fabrication and manufacturing for Diversified Ethanol. The company is intended to become part of Diversified Ethanol, and to work exclusively on Diversified Ethanol projects.

Diversified's CEO Taylor Moffitt said, "This acquisition won't just give us trucks, trailers, fuel tanks, welders, real estate, fork lifts, and fabrication tools ... it will give us the talent of John Newby, the greatest asset. With Newby's experience and leadership on our team, Diversified Ethanol can catapult into massive action. Newby can get us into production fast. He knows what he's doing."

Moffitt is negotiating the deal, which involves a mixture of cash and stock. JMCP CEO Chris McGovern has already written the check in anticipation of the pending closing.

This press release does not constitute an offer of any securities for sale. This press release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements involve certain risks and uncertainties that could cause actual results to differ, including, without limitation, the company's limited operating history and history of losses, the inability to successfully obtain further funding, the inability to raise capital on terms acceptable to the company, the inability to compete effectively in the marketplace, the inability to complete the proposed acquisition and such other risks that could cause the actual results to differ materially from those contained in the company's projections or forward-looking statements. All forward-looking statements in this press release are based on information available to the company as of the date hereof, and the company undertakes no obligation to update forward-looking statements to reflect events or circumstances occurring after the date of this press release.

SOURCE: James Monroe Capital Corporation


James Monroe Capital Corporation, Northbrook, IL
Chris McGovern, 847-418-3848
Copyright Business Wire 2006

[Dspetry]

Some like it HOT !!!!!

Right ladies

[Tina]

huff pant huff sweat huff

just came back from my afternoon walk ... OMG it's HOT out!

[Dspetry]

let Willy break north thru -80, then hit it!


Damn, that was quick...

Now where is my dry poweder at

[Dspetry]

OK, I will...

Got any cash I can borrow?

LoL

[dart1961]

Dspetry Agree let Willy break north thru -80, then hit it!

[Dspetry]

wouldn't ya wait until Willy broke up through -80?

[Dspetry]

wouldn't ya wait until Willy broke up through -80?

[dart1961]

NTN-chart Dspetry it's not bottomed out yet RSI still dropping could see 1.00 IMO! Wait 1 more day, but could take 1st small entry at 1.12

[bigarow]

CBAI + 24%/Cord Blood America Announces Record Revenues, Over $1 Million, in Second Quarter; Up 60 Percent From 2005
PR Newswire - August 17, 2006 5:01 AM (EDT)

LOS ANGELES, Aug 17, 2006 /PRNewswire-FirstCall via COMTEX/ -- Cord Blood America, Inc. (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company which is focused on bringing the life saving potential of stem cells to families nationwide (http://www.cordpartners.com), today announced that its revenues for the second quarter ended June 30, 2006 topped $1.067 million, up 60 percent compared to revenues of $665,582 for the same quarter in 2005.

Gross profit for the second quarter was up 62 percent to $298,572 compared to $184,853 in the same period in 2005. The Company announced a loss of $(1.27 million) compared to $(1.23 million) last year.

"Revenues for our previous highest quarter were $819, 814," said Matthew Schissler, CEO. "Our record revenues were accomplished by a singular desire of our team to deliver to the investors the best possible quarter. Some other reasons for increased revenues include: an increase in customer base and an increase in the number of payments received by customers choosing our annual payment option of $269."

In the program launched in 2005, Cord Blood America is the only company in the industry that will waive the initial fee of $1,695 for certain customers, allowing them to pay $269 six months after birth with subsequent 17 annual payments of $269. "This means that families that previously could not afford this potentially life saving service are now enrolling and we are harvesting the fruits of our industry-first, innovative payment plan," Mr. Schissler said.

Revenues for the six months ended June 30, 2006 totaled $1.72 million, up 16 percent compared to revenues of $1.48 million for the same period in 2005. Gross profit for the six months totaled $427,751 compared to $398,802 in the previous year. The Company announced a net loss of $(2.98 million) for the first six months compared to $(2.26 million) for the same period in 2005. At June 30, 2006 total assets increased 358 percent of $1.01 million compared to $220,700 at June 30, 2005.

About Cord Blood America

Cord Blood America (OTC Bulletin Board: CBAI) is the parent company of Cord Partners, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. To find out more about Cord Blood America, Inc. (OTC Bulletin Board: CBAI), visit our website at www.cordpartners.com. For investor information, visit www.cordblood-america.com.

[Dspetry]

Hey Dart..

My cousin is telling me he likes NTN down here.

I looked at the chart, and do not see it...

Can ya pop one up with your analyses for me at your convenience???

TIA,
Dave

[dart1961]

Hello all! BKMP-chart

This is my check for dilution chart,

I give a clean bill of health LOL! CMF-positive, ACC/Dist has been on a nice staedy rise accumulating nicely, OBV- gave a small headfake but should recover back above its signal line soon! Willy with a Bullish push above it's 50 level, put's BKMP poised for increasing it's PPS from here IMO!

[ddwalker87]

HBSC Post-Bell News After Strong Closing!!!

Off to the races tomorrow. Hope you're all on-board!!! Tomorrow is gonna be HUGE!!!

Human BioSystems Signs Project Agreement to Assist the Company in Evaluating Potential Partners of Its Preservation Technologies

Aug 15, 2006 4:05:00 PM

PALO ALTO, CALIFORNIA -- (MARKET WIRE) -- 08/15/06 -- Human BioSystems (OTCBB: HBSC) ("HBS" or "Company") announced today that it has signed an agreement with UTEK Corporation ("UTEK") to assist HBS in identifying and making introductions to potential business partners of the Company's preservation technology, including its above zero and below zero preservation technology for organs and other biomaterials, as well as its blood platelet preservation process.

According to Harry Masuda, CEO of Human BioSystems, "UTEK has contacts that are relevant to HBS technology and we are excited to establish this business relationship to utilize their expertise towards optimizing our process of selecting the right partner for each of our technologies. Partnering has been in our business plan from the beginning and it has been our goal to establish strategic partners who have the distribution channels required to sell our products worldwide."

HBS plans to market its preservation technologies worldwide, including a number of markets in the United States. The diversity of markets available to HBS makes the UTEK Project Agreement an essential step forward toward achieving the Company's goal of leveraging its efforts to bring products to market as quickly as possible. As UTEK helps to identify the appropriate partners for the HBS technologies, the Company can move forward in creating new markets for its preservation technologies.

"When we license a technology, we can segment and limit the license to a particular application, an example being the preservation of donor organs while excluding the application for islet cells. We may also elect to sell components of our technology such as packaged solutions to companies as a "general preservation solution" for research, which may result in commercial sales of our preservation solutions. In other words, licensing will not preclude us from entering non-licensed markets or activities," continued Mr. Masuda.

Human BioSystems is a developer of preservation platforms for organs and other biomaterials. The Company, which is headquartered in Palo Alto, California with research facilities in Michigan, has been granted four patents by the U.S. Patent Office. HBS also announced recently the signing of a letter of intent to enter the BioFuels business through the acquisition of two ethanol production facility projects from EXL III.

Certain statements contained herein are "forward-looking" statements (as such term is defined in the Private Securities Litigation Reform Act of 1995). Because such statements include risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Factors that could cause results to differ materially from those expressed or implied by such forward-looking statements include, but are not limited to, results from ongoing research and development as well as clinical studies, failure to obtain regulatory approval for the Company's products, if required, failure to develop a product based on the Company's technology, failure of any such products to compete effectively with existing products, the inability to find a strategic partner or to consummate a relationship with a potential strategic partner on acceptable terms, and other factors discussed in filings made by the Company with the Securities and Exchange Commission.

Contacts:
Human BioSystems
Harry Masuda
CEO
[phone]
[e-mail]


My posts are not buy or sell recommendation

[Stock Stallion]

jim, i am with you...way to hot. like trying to play golf on the surface of the sun LOL As for stocks i am in, only holding MLXO now and waiting for the BIG news. not much out there this week. will see what next week brings. I usually trade very light during the summer. the market is getting ready to gear up again in the fall, so i will be ready then. just passing time for now. how about you??/ anything you think is interesting out there?

[jimaustin]

Yep, I havn't played golf in 2 weeks...too hot in Austin. sheesh can't wait for a cool spell.

What stocks are you playing??

[Tina]

Hi Posters,

I will be taking a short iHub break. I do this every so often from the internet to focus on health goals (in other words, working out to prevent my butt from expanding to the width of my chair)lol.

I'll be checking in periodically.

See ya soon,
Tina

[Stock Stallion]

same here, 104 yesterday and looks to be around 103 today here in good ole TX. Staying indoors and doing as little as possible, if i can get away with it :)

[Outlawbabe]

Doing ok here. Putting the "finishing touches" on last 2 rental properties so the new renters can move in.... it's miserable here - over 100 degrees for DAYS!

How goes it with you ladies?

[Stock Stallion]

hey outlaw, how you doing?

[Tina]

morning outlaw!!

[Tina]

good morning....Legal. It's hard to say.

[Outlawbabe]

Good morning Legal, Tina! :)

[Stock Stallion]

good morning board! when is DD suppose to get paroled :)

[mick]

yes and it is beautiful here is az.

are ya watching PFNC?

[Tina]

good afternoon mick. hope you're having a good day =)

[mick]

good morning posters.

[IRISHBULL]

LOL Break out the "Will work for bail" sign..

[Stock Stallion]

lol ya got me there :) morning tina :)

[Tina]

is there such a thing???? lol

good morning legal =)

[Stock Stallion]

LOL you need to run with a better crowd tina LOL

[Tina]

Looks like my co mod is incarcerated.

Unfortunately, all my PPS are too low to post bail money lol

[mick]

hi tina, good morning to ya and to all. we are having a nice weekend. i hope you are too.

[Tina]

Nice to see you mick! Hope you're having a great weekend =)

[mick]

o.k. mr DD, thanx

[MR DD]

Mick glad to have you here.


don't forget to post some of your up and coming picks.

[mick]

i just ran across the forum. very nice stuff.

[ddwalker87]

HBSC -- Big Things Expected Monday!!!

Don't Miss Out!!!

[MR DD]

Once again BIGDADDY turns out to be Full of It

XKEM Steve Burg is still waiting to recieve the projected numbers,Bigdaddy said he had them already.

I expect them to be out Monday or Tuesday,that is why I'm topping the tank off today.

[Tina]

Good morning everyone.... TGIF!!!

[MR DD]

XKEM

filing should be out on the 15th and if late the 22th


stock should start a move to the up side tomorrow.


next week we should be the #1 board again

[MR DD]

does any one know how much money XKEM has gotten from grants for research if any.

[ddwalker87]

ACMG Update From the CEO

MONTREAL, Aug 10, 2006 (MARKET WIRE via COMTEX) -- The following is an update presented by Alexander P. Cavasin, CEO of Alcar Chemicals Group Inc. (PINKSHEETS: ACMG), on the corporation's activities and progress.
Although news has been far and in between, progress has been steady on all fronts and several developments took shape as planned. A more detailed update is available on our website where I posted a letter to our shareholders, please feel free to download it at your convenience. This letter is the first of what I hope will become a new tradition for us, posting our progress on a regular basis and include answers to the questions you have about your company.

Funding -- we have opted for an alternative financing strategy by using private placements, cash for restricted shares, without callable secured convertible notes attached to these. By proceeding with multiple smaller trenches, we will minimize dilution while keeping the progress on schedule. A first contract has been finalized and the initial trench has been received, these funds were mainly dedicated to engineering with a 10% portion allocated to the new administration offices. Another significant trench will be due early September.

Facilities & Operations -- we concluded a long-term lease and will be moving into our new administration offices on the coming Monday. With savings on initial office set-up as well as significant long term cost savings, the decision to separate administration and operations is mainly based on economy.

The building selected for our manufacturing facilities is presently still under negotiations, I expect these to be completed within the next three to four weeks to allow us to remain on schedule with building occupation and installations as planned to begin during the month of September.

The decision to separate operations and administration resulted in almost half a million dollars in up-front cost savings.

Other activities -- with the forecasted financing structure, we were comfortable stating that the milestone for filing and becoming fully reporting had moved up about three months from late spring, early summer to early spring. We now believe that, with additional funds available for auditing and filing, we may be fully compliant several weeks ahead of schedule.

Our financials are presently being audited and we will post these on our site as soon as the auditing is completed.

We are presently negotiating IR/PR contracts and I am confident we will be in a position to reach an agreement with two firms within the next few weeks. This will allow us to make true on my promise to increase information flow and visibility for our company.

Marketing gave way to the intense negotiations and preparation activities which had to take priority, especially considering the two contracts requiring the full production capacity of three reactors. My meeting with M. Terki to group the contracts and develop a delivery schedule was postponed to the end of September.

About Alcar Chemicals Group

The Alcar Chemicals Group (PINKSHEETS: ACMG) represents a significant market opportunity due to a serious worldwide supply shortage of raw materials for polymers as well as an increased requirement for ethanol and biodiesel. ACMG has been concentrating on innovative methods for biomass valorisation for the past decade, specifically petroleum-independent fuel and plastics resin production. It's proprietary technology represents today's most economical and advanced manufacturing process for plastic raw materials, ethanol and bio-diesel, allowing production at cost savings of up to 40% when compared to current production methods.

Please visit our website: www.alcarchemicalsgroup.com

To hear more about ACMG from Alexander P. Cavasin go to: http://www.publiccoreport.net/featured/ACMG/company.asp

Important Information About Forward-Looking Statements

All statements and information in this news release, other than historical facts, are forward-looking statements, which contain our current expectations about our future results. Forward-looking statements involve numerous risks and uncertainties which are subject to section 27A of the Securities Act of 1933 and section 21E of the Exchange Act of 1934, and are subject to safe harbor created by these sections. We have attempted to identify any forward-looking statements by using words such as "anticipates", "believes", "could", "expects", "intends", "may", "should" and other similar expressions. Although we believe that the expectations reflected in all of our forward-looking statements are reasonable, we can give no assurance that such expectations will prove to be correct and actual results may vary.

A number of factors may affect our future results and may cause those results to differ materially from those indicated in any forward-looking statements made by us or on our behalf. Such factors include our limited operating history; our need for significant capital to finance internal growth as well as strategic acquisitions; our ability to attract and retain key employees and strategic partners; our ability to achieve and maintain profitability; fluctuations in the trading price and volume of our stock; competition from other providers of similar products and services; and other unanticipated future events and conditions.



Contact Info:
Homer Pateridis
Investor relations consultant
Tel [phone]
[e-mail] www.AlcarChemicalsGroup.com

SOURCE: Alcar Chemicals Grp

[ddwalker87]

ETYN Getting Ready To Run!!!

6M float!

http://www.americanbulls.com/StockPage.asp?CompanyTicker=ETYN&MarketTicker=OTC&TYP=S

[MR DD]

Gates Foundation can help XKEM

Priority Diseases and Conditions



Fighting Diseases of the Developing World
We support efforts to prevent and treat diseases and conditions that meet three criteria: (1) they cause widespread illness and death in developing countries; (2) they represent the greatest inequities in health between developed and developing countries; and (3) they receive inadequate attention and funding.

To learn more about our priority diseases and conditions, please see the specific sections listed below.





Our priority diseases and conditions are:

Acute Diarrheal Illness

The foundation helps fund work aimed at preventing and treating infectious diarrhea, which contributes to the deaths of 2 million to 3 million young children each year.



Acute Lower Respiratory Infections

Respiratory illnesses like pneumonia kill about 2 million young children every year. The foundation aids efforts to improve diagnosis and develop better vaccines against these common infections.



Child Health

Much of the work on specific diseases supported by the foundation benefits children. In addition, we assist in broader efforts to improve child survival, by supporting efforts to prevent millions of deaths among newborns.




HIV/AIDS

To slow the global spread of HIV, the foundation supports the development of vaccines and other tools and strategies with the potential to prevent tens of millions of infections and deaths. We also fund comprehensive initiatives that include both prevention and treatment.




Malaria

The foundation’s grantees are working in many areas to reduce the burden of malaria on the world’s poorest countries. Their work includes the development of vaccines to prevent the disease and large-scale efforts to control malaria by making better use of existing tools.




Poor Nutrition

The foundation assists efforts to improve nutrition, including developing foods and crops that are high in essential vitamins and minerals, and ensuring that healthy foods get to those who need them most.



Reproductive and Maternal Health

To improve the health of women in the developing world, the foundation supports efforts to reduce deaths and illness related to pregnancy and prevent unintended pregnancies.



Tuberculosis

The foundation supports work in the prevention and treatment of TB, including the search for improved vaccines, better tools for diagnosis, and new drugs to treat active TB.




Vaccine-Preventable Diseases

The foundation supports the Global Alliance for Vaccines and Immunization, an innovative partnership that has helped save hundreds of thousands of lives by increasing the number of children who receive basic vaccines.





Other Infectious Diseases

Developing countries are disproportionately affected by other common diseases, including sexually transmitted infections, infections involving multicellular organisms such as worms, and those caused by parasites transmitted through insects.













Jul 26, 2006
Hopkins’ CCP Launches New Advocacy Program to Promote...


Jul 24, 2006
University of Leeds receives Gates Foundation Grant...


Jul 19, 2006
Foundation Funds Major New Collaboration to Accelerate...


More...










2006


2005


2000-2004


1994-1999










Avahan: India AIDS Initiative


Global HIV Vaccine Enterprise

[MR DD]

Global Health





The foundation's global health mission is to help ensure that lifesaving advances in health are created and shared with those who need them most.

We focus on accelerating access to existing vaccines, drugs, and other tools to fight diseases that disproportionately affect developing countries, and we support research to discover new health solutions that are effective, affordable, and practical for use in poor countries.








--------------------------------------------------------------------------------
Highlights
Fighting the Forgotten Diseases
We recognize the Carter Center's pioneering health care in developing countries, especially the Center's program to eradicate Guinea worm disease.





Protecting Women from HIV/AIDS
Melinda French Gates writes about the spread of HIV, why women are especially vulnerable, and the important role science plays in preventing infection.





Grantees Make Progress
From immunizing children to tackling the spread of HIV/AIDS, foundation grantees are working to improve the health of people in developing countries around the world. Read an overview of their progress. (127 KB PDF)






--------------------------------------------------------------------------------

The program supports a wide variety of work united by the goal of reducing inequities in health:

Priority Diseases and Conditions

Health issues that cause relatively few problems in developed countries continue to spread sickness and death in poorer regions of the world. The foundation concentrates its support on efforts to prevent and treat these diseases and conditions.




Breakthrough Science

For each of the priority diseases and conditions, the foundation supports scientific research to develop new and better tools for preventing and treating disease.




Other Initiatives

To make a difference, new tools and strategies for better health must be available to those who need them most. The foundation supports projects that help finance, test, deliver, and sustain access to health interventions.

We also support locally developed programs to improve community health, and issue discretionary grants for emergency relief during extraordinary events.


From The Gates Site



For Global Health Program Grant Seekers

This section explains the foundation’s global health strategy, priority areas for grantmaking, and how to apply for a grant.

The information here will help you to determine whether your project matches the foundation’s priorities and scope of giving before requesting funding.

[MR DD]

GATES COULD HELP XKEM

from the 10Q

We expect to continue our development efforts with respect to antifungal, anticancer, antiviral (including anti-AIDS) and anti-inflammatory compounds, as well as antiaging and memory enhancing compounds. Although we do not expect product revenues from these sources in 2006, we anticipate that these development activities may allow us to enter into more favorable licensing and/or investment arrangements.


XKEM needs to solicit the Gates foundation to help with research dollars to develop some of the other drugs XKEM is working on.


XKEM is real and BM knows it so should the Gates Foundation.

[MR DD]

GATES~IS ONE STEP CLOSER TO XKEM


with the recent 500 million for TB and Aids,I think we have a chance to get in on this.Africa seems to be getting attention from this foundation and Sickle Cell could be next.